Authors: Derun Li, Yongqi Deng, Abdelghani Achab, Indu Bharathan, Brett A. Hopkins, Wensheng Yu, Hongjun Zhang, Sulagna Sanyal, Qinglin Pu, Hua Zhou, K. Liu, Jongwon Lim, Xavier Fradera, Charles A. Lesburg, Alfred Lammens, Theodore A. Martinot, Ryan D. Cohen, Amy C. Doty, Heidi M. Ferguson, Elliott Nickbarg, Mangeng Cheng, Peter Spacciapoli, Prasanthi Geda, Xuelei S. Song, Nadya Smotrov, Pravien Abeywickrema, Christine L. Andrews, Chad Chamberlin, Omar S. Mabrouk, Patrick J. Curran, Matthew Richards, P Saradjian, J. Richard Miller, Ian Knemeyer, Karin M. Otte, Stella Vincent, Nunzio Sciammetta, Alexander Pasternak, David Jonathan Bennett, Yongxin Han - ACS Medicinal Chemistry Letters 2021 cited by 26
is a potent IDO1 inhibitor, with clean off-target profiles and the potential for quaque die dosing in humans.
